Stock Events

Stock Events

enGene Therapeutics (ENGN) Q1 2025 Earnings

10MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.48

-0.41

-0.33

-0.26

Details

Expected EPS

-0.367786

Actual EPS

-0.48

Surprise EPS

-0.11

Surprise Percent

+30.51%

Description

enGene Therapeutics (ENGN) has reported earnings of -0.48 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.